CpG and poly(I:C) stimulation of dendritic cells and fibroblasts limits herpes simplex virus type 1 infection in an IFNβ-dependent and -independent way

Antiviral Research

Volumn 93, Issue 1, 2012, Pages 39-47

  Gaajetaan, Giel R ^a   Geelen, Tanja H ^a   Grauls, Gert E ^a   Bruggeman, Cathrien A ^a   Stassen, Frank R ^a,b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Dendritic cell; HSV 1; Interferon; Toll like receptor

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; POLYINOSINIC POLYCYTIDYLIC ACID;

ANIMAL EXPERIMENT; ANTIVIRAL ACTIVITY; ARTICLE; BONE MARROW CELL; CELL STIMULATION; CONTROLLED STUDY; CPG ISLAND; DENDRITIC CELL; FIBROBLAST; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; IN VITRO STUDY; LIMIT OF DETECTION; MALE; MOUSE; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; VIRUS INHIBITION; VIRUS PARTICLE; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; CERCOPITHECUS AETHIOPS; DENDRITIC CELLS; DNA; FIBROBLASTS; HERPESVIRUS 1, HUMAN; INTERFERON-BETA; MALE; MICE; MICE, INBRED BALB C; POLY I-C; TOLL-LIKE RECEPTORS; VERO CELLS; VIRUS REPLICATION;

HUMAN HERPESVIRUS 1;

EID: 84355162855     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2011.10.015     Document Type: Article

References (46)

1. Baig E., Fish E.N. Distinct signature type I interferon responses are determined by the infecting virus and the target cell. Antivir. Ther. 2008, 13:409-422.
2. Barchet W., Cella M., Colonna M. Plasmacytoid dendritic cells-virus experts of innate immunity. Semin. Immunol. 2005, 17:253-261.
3. Blasius A.L., Beutler B. Intracellular toll-like receptors. Immunity 2010, 32:305-315.
4. Boivin N., Sergerie Y., Rivest S., Boivin G. Effect of pretreatment with toll-like receptor agonists in a mouse model of herpes simplex virus type 1 encephalitis. J. Infect. Dis. 2008, 198:664-672.
5. Borden E.C., Sen G.C., Uze G., Silverman R.H., Ransohoff R.M., Foster G.R., Stark G.R. Interferons at age 50: past, current and future impact on biomedicine. Nat. Rev. Drug Discov. 2007, 6:975-990.
6. Bowie A.G., Unterholzner L. Viral evasion and subversion of pattern-recognition receptor signalling. Nat. Rev. Immunol. 2008, 8:911-922.
7. Brawand P., Fitzpatrick D.R., Greenfield B.W., Brasel K., Maliszewski C.R., De Smedt T. Murine plasmacytoid pre-dendritic cells generated from Flt3 ligand-supplemented bone marrow cultures are immature APCs. J. Immunol. 2002, 169:6711-6719.
8. Cao W., Liu Y.J. Innate immune functions of plasmacytoid dendritic cells. Curr. Opin. Immunol. 2007, 19:24-30.
9. Coccia E.M., Severa M., Giacomini E., Monneron D., Remoli M.E., Julkunen I., Cella M., Lande R., Uze G. Viral infection and Toll-like receptor agonists induce a differential expression of type I and lambda interferons in human plasmacytoid and monocyte-derived dendritic cells. Eur. J. Immunol. 2004, 34:796-805.
10. Compton T., Kurt-Jones E.A., Boehme K.W., Belko J., Latz E., Golenbock D.T., Finberg R.W. Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. J. Virol. 2003, 77:4588-4596.
11. Der S.D., Zhou A., Williams B.R., Silverman R.H. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc. Natl Acad. Sci. USA 1998, 95:15623-15628.
12. Fitzgerald-Bocarsly P., Dai J., Singh S. Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history. Cytokine Growth Factor Rev. 2008, 19:3-19.
13. Fitzgerald-Bocarsly P., Feng D. The role of type I interferon production by dendritic cells in host defense. Biochimie 2007, 89:843-855.
14. Gautier G., Humbert M., Deauvieau F., Scuiller M., Hiscott J., Bates E.E., Trinchieri G., Caux C., Garrone P. A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells. J. Exp. Med. 2005, 201:1435-1446.
15. Gibson S.J., Lindh J.M., Riter T.R., Gleason R.M., Rogers L.M., Fuller A.E., Oesterich J.L., Gorden K.B., Qiu X., McKane S.W., Noelle R.J., Miller R.L., Kedl R.M., Fitzgerald-Bocarsly P., Tomai M.A., Vasilakos J.P. Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod. Cell. Immunol. 2002, 218:74-86.
16. Gill N., Deacon P.M., Lichty B., Mossman K.L., Ashkar A.A. Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production. J. Virol. 2006, 80:9943-9950.
17. Gilliet M., Boonstra A., Paturel C., Antonenko S., Xu X.L., Trinchieri G., O'Garra A., Liu Y.J. The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 2002, 195:953-958.
18. Gitlin L., Barchet W., Gilfillan S., Cella M., Beutler B., Flavell R.A., Diamond M.S., Colonna M. Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc. Natl Acad. Sci. USA 2006, 103:8459-8464.
19. Guiducci C., Ott G., Chan J.H., Damon E., Calacsan C., Matray T., Lee K.D., Coffman R.L., Barrat F.J. Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation. J. Exp. Med. 2006, 203:1999-2008.
20. Haller O., Kochs G., Weber F. The interferon response circuit: induction and suppression by pathogenic viruses. Virology 2006, 344:119-130.
21. Hemmi H., Kaisho T., Takeuchi O., Sato S., Sanjo H., Hoshino K., Horiuchi T., Tomizawa H., Takeda K., Akira S. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat. Immunol. 2002, 3:196-200.
22. Ito T., Kanzler H., Duramad O., Cao W., Liu Y.J. Specialization, kinetics, and repertoire of type 1 interferon responses by human plasmacytoid predendritic cells. Blood 2006, 107:2423-2431.
23. Ito T., Wang Y.H., Liu Y.J. Plasmacytoid dendritic cell precursors/type I interferon-producing cells sense viral infection by Toll-like receptor (TLR) 7 and TLR9. Springer Semin. Immunopathol. 2005, 26:221-229.
24. Kato H., Takeuchi O., Sato S., Yoneyama M., Yamamoto M., Matsui K., Uematsu S., Jung A., Kawai T., Ishii K.J., Yamaguchi O., Otsu K., Tsujimura T., Koh C.S., Reis e Sousa C., Matsuura Y., Fujita T., Akira S. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006, 441:101-105.
25. Katze M.G., Fornek J.L., Palermo R.E., Walters K.A., Korth M.J. Innate immune modulation by RNA viruses: emerging insights from functional genomics. Nat. Rev. Immunol. 2008, 8:644-654.
26. Katze M.G., He Y., Gale M. Viruses and interferon: a fight for supremacy. Nat. Rev. Immunol. 2002, 2:675-687.
27. Kawai T., Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 2010, 11:373-384.
28. Kim T.W., Staschke K., Bulek K., Yao J., Peters K., Oh K.H., Vandenburg Y., Xiao H., Qian W., Hamilton T., Min B., Sen G., Gilmour R., Li X. A critical role for IRAK4 kinase activity in Toll-like receptor-mediated innate immunity. J. Exp. Med. 2007, 204:1025-1036.
29. Krug A., Rothenfusser S., Hornung V., Jahrsdorfer B., Blackwell S., Ballas Z.K., Endres S., Krieg A.M., Hartmann G. Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells. Eur. J. Immunol. 2001, 31:2154-2163.
30. Kurt-Jones E.A., Chan M., Zhou S., Wang J., Reed G., Bronson R., Arnold M.M., Knipe D.M., Finberg R.W. Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc. Natl Acad. Sci. USA 2004, 101:1315-1320.
31. Kurt-Jones E.A., Popova L., Kwinn L., Haynes L.M., Jones L.P., Tripp R.A., Walsh E.E., Freeman M.W., Golenbock D.T., Anderson L.J., Finberg R.W. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol. 2000, 1:398-401.
32. Lauterbach H., Bathke B., Gilles S., Traidl-Hoffmann C., Luber C.A., Fejer G., Freudenberg M.A., Davey G.M., Vremec D., Kallies A., Wu L., Shortman K., Chaplin P., Suter M., O'Keeffe M., Hochrein H. Mouse CD8alpha+ DCs and human BDCA3+ DCs are major producers of IFN-lambda in response to poly IC. J. Exp. Med. 2010, 207:2703-2717.
33. Li J., Hu S., Zhou L., Ye L., Wang X., Ho J., Ho W. Interferon lambda inhibits herpes simplex virus type I infection of human astrocytes and neurons. Glia 2011, 59:58-67.
34. Liu Y.J. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu. Rev. Immunol. 2005, 23:275-306.
35. Lore K., Betts M.R., Brenchley J.M., Kuruppu J., Khojasteh S., Perfetto S., Roederer M., Seder R.A., Koup R.A. Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses. J. Immunol. 2003, 171:4320-4328.
36. McHutchison J.G., Lawitz E.J., Shiffman M.L., Muir A.J., Galler G.W., McCone J., Nyberg L.M., Lee W.M., Ghalib R.H., Schiff E.R., Galati J.S., Bacon B.R., Davis M.N., Mukhopadhyay P., Koury K., Noviello S., Pedicone L.D., Brass C.A., Albrecht J.K., Sulkowski M.S. Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection. N. Engl. J. Med. 2009, 361:580-593.
37. Rustgi V.K. Safety of small molecules in combination with interferon-based therapy for hepatitis C virus. Expert Opin. Drug Saf. 2010, 9:883-892.
38. Sadler A.J., Williams B.R. Interferon-inducible antiviral effectors. Nat. Rev. Immunol. 2008, 8:559-568.
39. Schmittgen T.D., Livak K.J. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 2008, 3:1101-1108.
40. Schmitz F., Heit A., Guggemoos S., Krug A., Mages J., Schiemann M., Adler H., Drexler I., Haas T., Lang R., Wagner H. Interferon-regulatory-factor 1 controls Toll-like receptor 9-mediated IFN-beta production in myeloid dendritic cells. Eur. J. Immunol. 2007, 37:315-327.
41. Sulkowski M.S., Cooper C., Hunyady B., Jia J., Ogurtsov P., Peck-Radosavljevic M., Shiffman M.L., Yurdaydin C., Dalgard O. Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C. Nat. Rev. Gastroenterol. Hepatol. 2011, 8:212-223.
42. Trinchieri G., Sher A. Cooperation of Toll-like receptor signals in innate immune defence. Nat. Rev. Immunol. 2007, 7:179-190.
43. Wilkins C., Gale M. Recognition of viruses by cytoplasmic sensors. Curr. Opin. Immunol. 2010, 22:41-47.
44. Wong J.P., Christopher M.E., Viswanathan S., Karpoff N., Dai X., Das D., Sun L.Q., Wang M., Salazar A.M. Activation of toll-like receptor signaling pathway for protection against influenza virus infection. Vaccine 2009, 27:3481-3483.
45. Yasuda K., Richez C., Uccellini M.B., Richards R.J., Bonegio R.G., Akira S., Monestier M., Corley R.B., Viglianti G.A., Marshak-Rothstein A., Rifkin I.R. Requirement for DNA CpG content in TLR9-dependent dendritic cell activation induced by DNA-containing immune complexes. J. Immunol. 2009, 183:3109-3117.
46. Yoneyama M., Fujita T. RNA recognition and signal transduction by RIG-I-like receptors. Immunol. Rev. 2009, 227:54-65.